FCGR2A and acute myeloid leukemia: RT1(9a) Kit+Sca1−/lowCD34− AML cells exhibited variable combinations of FcgR, CD48, and CD14 (Fig. 4C), suggesting that leukemias may have developed from different subclones within that compartment.